Related Experiment Video
Updated: Apr 9, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer
Chun-Te Wu1,2, Wei-Yu Lin2,3, Ying-Hsu Chang2,4
1Department of Urology, Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan.
Abstract:
The aim of this study was to examine the role of miRNAs regulation by DNMT1 and its underlying mechanisms in bladder cancer. The choice of target miRNAs was based on the analysis of a TaqMan MicroRNA Panel assay. The role of target miRNA in tumor behavior and the related signaling pathways were assessed using the human bladder cancer cell lines. We also evaluated the predictive power of the target miRNA and its link to DNMT1 from 124 clinical bladder cancer specimens. Our results revealed that the miR-424 level is significantly increased when blocking DNMT1 in bladder cancer cells. From the clinical specimen analysis, the staining of miR-424 was inversely correlated with DNMT1 immunoreactivity. The lack of miR-424 expression was significantly linked to aggressive tumor growth, advanced clinical stage and poor prognosis in bladder cancer. Increased miR-424 suppressed the tumor growth rate and invasion ability determined in vitro and in vivo. Furthermore, the EGFR pathway plays a role in the transmission of the miR-424 signal that regulates cell growth and the epithelial-to-mesenchymal transition. These results highlight a potential role for miR-424 as a molecular predictor and therapeutic target in bladder cancer.
Insights
MicroRNA-424 (miR-424) is regulated by DNMT1 in bladder cancer. Increased miR-424 suppresses tumor growth and invasion, indicating its potential as a biomarker and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Epigenetic modifications, including DNA methylation, play a crucial role in cancer development.
- DNA methyltransferase 1 (DNMT1) is implicated in regulating gene expression in various cancers.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are often dysregulated in cancer.
Purpose of the Study:
- To investigate the regulatory relationship between DNMT1 and specific miRNAs in bladder cancer.
- To elucidate the functional role of target miRNAs in bladder cancer progression and signaling pathways.
- To assess the clinical significance of target miRNAs as predictive biomarkers for bladder cancer.
Main Methods:
- miRNA profiling using TaqMan MicroRNA Panel assay.
- Functional studies in human bladder cancer cell lines (in vitro and in vivo).
- Analysis of 124 clinical bladder cancer specimens for miRNA and DNMT1 expression.
Main Results:
- DNMT1 inhibition led to a significant increase in miR-424 levels in bladder cancer cells.
- miR-424 expression was inversely correlated with DNMT1 immunoreactivity in clinical specimens.
- Lack of miR-424 expression was associated with aggressive tumor growth, advanced stage, and poor prognosis.
- Overexpression of miR-424 suppressed tumor growth and invasion.
- The EGFR pathway mediates miR-424's effects on cell growth and epithelial-to-mesenchymal transition.
Conclusions:
- miR-424 is epigenetically regulated by DNMT1 in bladder cancer.
- miR-424 acts as a tumor suppressor by inhibiting growth and invasion.
- miR-424 holds potential as a prognostic biomarker and therapeutic target for bladder cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
lncRNA - Long Non-coding RNAs

